These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25434516)

  • 1. [Current approaches for early detection and treatment of medication-related osteonecrosis of jaw].
    Janovszky Á; Vereb T; Szabó A; Piffkó J
    Orv Hetil; 2014 Dec; 155(49):1960-6. PubMed ID: 25434516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of bisphosphonate-related osteonecrosis of the jaw: a literature review.
    Spanou A; Lyritis GP; Chronopoulos E; Tournis S
    Oral Dis; 2015 Nov; 21(8):927-36. PubMed ID: 25732104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bisphosphonate-related osteonecrosis of the jaw].
    Atanes-Bonome P; Atanes-Bonome A; Ríos-Lage P; Atanes-Sandoval AD
    Semergen; 2014 Apr; 40(3):143-8. PubMed ID: 24001573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management].
    Dupic G; Collangettes D; Dillies AF; Calvet L; Tournilhac O; Bay JO; Mahammedi H
    Bull Cancer; 2015 Dec; 102(12):1010-9. PubMed ID: 26607453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An office-based approach to the diagnosis and management of osteonecrosis.
    Ruggiero SL
    Atlas Oral Maxillofac Surg Clin North Am; 2013 Sep; 21(2):167-73. PubMed ID: 23981492
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of early detection of bisphosphonate-related osteonecrosis of the jaw.
    Mori M; Koide T; Matsui Y; Matsuda T
    Indian J Pharmacol; 2015; 47(3):334-5. PubMed ID: 26069377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current evidence-based approaches and international guidelines in primary and secondary prevention strategies of medication-related osteonecrosis of the jaws].
    Vereb T; Janovszky Á; Mucsi M; Piffkó J; Seres L
    Orv Hetil; 2020 Feb; 161(6):214-223. PubMed ID: 32008346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New trends in adjunctive treatment and diagnosis in medication-related osteonecrosis of the jaw: A 10-year review.
    De Santis D; Gelpi F; Luciano U; Zarantonello M; Poscolere A; Modena N; Faccioni P; Causarano G; Finotti M; Zotti F; Magi M; Iurlaro A; Nocini PF; Alberti C; Zangani A; Capocasale G; Donadello D; Nocini R; Bernardello F
    J Biol Regul Homeost Agents; 2020; 34(6 Suppl. 2):37-48. PubMed ID: 33541063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiresorptives and osteonecrosis of the jaw.
    Yamashita J; McCauley LK
    J Evid Based Dent Pract; 2012 Sep; 12(3 Suppl):233-47. PubMed ID: 23040351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pentoxifylline and α-tocopherol on medication-related osteonecrosis of the jaw in rats: Before and after dental extraction.
    Delfrate G; Mroczek T; Mecca LEA; Andreis JD; Fernandes D; Lipinski LC; Claudino M; Franco GCN
    Arch Oral Biol; 2022 May; 137():105397. PubMed ID: 35286947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Considerations of elderly patient's dental rehabilitation treated with bisphophonate].
    Bata Z; Vasziné Szabó E; Tóth Z
    Orv Hetil; 2018 Dec; 159(48):2031-2036. PubMed ID: 30501524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive Strategies for Patients at Risk of Medication-related Osteonecrosis of the Jaw.
    Goodday RH
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):527-36. PubMed ID: 26293331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term perioperative teriparatide therapy for the prevention of medication-related osteonecrosis of the jaw: A randomized, controlled preclinical study in rats.
    Zandi M; Dehghan A; Mohammadi-Mofrad A; Amini P; Vahdatinia F
    J Craniomaxillofac Surg; 2017 Feb; 45(2):275-280. PubMed ID: 28087282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy.
    Lee JJ; Cheng SJ; Jeng JH; Chiang CP; Lau HP; Kok SH
    Head Neck; 2011 Sep; 33(9):1366-71. PubMed ID: 20310042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent treatment for medication-related osteonecrosis of the jaw].
    Ota Y; Sasaki M
    Clin Calcium; 2016 Apr; 26(4):612-21. PubMed ID: 27013633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The risk of bisphosphonate-related osteonecrosis of the jaw].
    Polymenidi I; Trombetti A; Carballo S
    Rev Med Suisse; 2014 Oct; 10(446):1930-4. PubMed ID: 25438377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays.
    Damm DD; Jones DM
    Gen Dent; 2013 Aug; 61(5):33-8. PubMed ID: 23928436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings.
    Kakehashi H; Ando T; Minamizato T; Nakatani Y; Kawasaki T; Ikeda H; Kuroshima S; Kawakami A; Asahina I
    Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1558-64. PubMed ID: 26304604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study.
    Keskinruzgar A; Bozdag Z; Aras MH; Demir T; Yolcu U; Cetiner S
    J Oral Maxillofac Surg; 2016 Jan; 74(1):68-78. PubMed ID: 26215490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.